Physician profile
Daniel Gruber
NPI 1841225133
$90,836.83
in general payments reported to CMS, 2019-2025
16 companies · $25K in 2025
The $25K reported for 2025 was more than what 97% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $481 · 2021: $18K · 2022: $14K · 2023: $18K · 2024: $15K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44K · Consulting Fee: $5,145 · Food and Beverage: $4,917 · Travel and Lodging: $3,778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $44,300.00 |
| Consulting Fee | $5,145.00 |
| Food and Beverage | $4,916.50 |
| Travel and Lodging | $3,777.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $58,464.51 | 2022-2025 | |
| Allergan, INC. | $12,544.85 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $7,661.87 | 2019-2023 | Exparel |
| Caldera Medical, INC | $6,970.03 | 2021-2025 | Desara |
| Axonics, INC. | $1,740.94 | 2021-2024 | Axonics |
| Boston Scientific Corporation | $1,505.59 | 2019-2025 | Upsylon, General - Therapies, Solyx Sis System |
| Coloplast Corp | $1,377.42 | 2019-2025 | Altis, Saffron |
| Renovia INC | $143.51 | 2019 | |
| Coopersurgical, INC. | $104.64 | 2022 | |
| Integra Lifesciences Corporation | $84.97 | 2022-2023 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Sumitomo Pharma America, INC. | $81.33 | 2023-2024 | Myfembree |
| Medtronic USA, INC. | $50.64 | 2019 | |
| Bluewind Medical | $37.49 | 2024-2025 | Revi |
| Merck Sharp & Dohme LLC | $26.08 | 2023 | Keytruda |
| Abbott Laboratories | $22.03 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valencia Technologies Corporation | $20.93 | 2023 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gruber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.